Diplomat Pharmacy Commences IPO - Quick Facts

(RTTNews) - Diplomat Pharmacy, Inc. (DPLO) announced it has commenced initial public offering of 13,333,333 shares of common stock. The company is selling 10 million shares of common stock and certain selling shareholders of Diplomat are selling 3,333,333 shares of common stock. The initial public offering price is currently expected to be between $14.00 and $16.00 per share.

Diplomat serves patients and physicians in all 50 states as the nation's largest independent specialty pharmacy. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions.

Diplomat expects to use the net proceeds to repay indebtedness and for working capital and other general corporate purposes. The company's common stock has been approved for listing on the NYSE under the symbol, DPLO.